Kennedy Capital Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-21,887
Closed -$157K 756
2018
Q4
$157K Sell
21,887
-48
-0.2% -$535 ﹤0.01% 687
2018
Q3
$419K Sell
21,935
-237
-1% -$8.46K 0.01% 689
2018
Q2
$1.25M Buy
+22,172
New +$1.12M 0.02% 651
2017
Q2
Sell
-63,921
Closed -$4.63M 781
2017
Q1
$4.63M Sell
63,921
-728
-1% -$48.1K 0.08% 448
2016
Q4
$3.7M Buy
64,649
+49,710
+333% +$4.55M 0.06% 493
2016
Q3
$1.91M Buy
+14,939
New +$1.91M 0.04% 580
2015
Q4
Sell
-11,532
Closed -$1.41M 772
2015
Q3
$1.41M Sell
11,532
-43
-0.4% -$5.84K 0.03% 626
2015
Q2
$1.78M Sell
11,575
-11,362
-50% -$1.87M 0.03% 608
2015
Q1
$3.92M Sell
22,937
-29
-0.1% -$4.39K 0.07% 462
2014
Q4
$3.51M Buy
22,966
+17,136
+294% +$2.14M 0.06% 481
2014
Q3
$618K Buy
+5,830
New +$812K 0.01% 699

Other funds holding ELGX

Kennedy Capital Management's ELGX Position: Q1 2019 in Review

Kennedy Capital Management sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 21,887 shares — an estimated $157K sold.

Kennedy Capital Management first reported a position in ELGX in Q3 2014 and held it in 11 quarters. The position peaked at $4.63M in Q1 2017. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

  • Kennedy Capital Management reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
  • Kennedy Capital Management sold 21,887 Endologix Inc shares in Q1 2019, an estimated $157K.
  • Kennedy Capital Management first reported a position in Endologix Inc in Q3 2014 and held it in 11 quarters.
  • Kennedy Capital Management's Endologix Inc position peaked at $4.63M in Q1 2017.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Kennedy Capital Management's 13F filing for Q1 2019, filed 13 May 2019.